Selected research
Market Structure
Global Medical Antithrombotic Coatings Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Antithrombotic Coatings market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Antithrombotic Coatings is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Antithrombotic Coatings include Thermal Spray Technologies, Surmodics, Surface Solutions Group, Specialty Coating Systems (SCS), Hydromer, Harland Medical Systems, Coatings2Go and Biocoat, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Medical Antithrombotic Coatings output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Medical Antithrombotic Coatings by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Medical Antithrombotic Coatings market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Antithrombotic Coatings and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Antithrombotic Coatings sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Antithrombotic Coatings market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Antithrombotic Coatings Segment by Company
Thermal Spray Technologies
Surmodics
Surface Solutions Group
Specialty Coating Systems (SCS)
Hydromer
Harland Medical Systems
Coatings2Go
Biocoat
Medical Antithrombotic Coatings Segment by Type
Phosphorylcholine
PEG Coating
Heparin Coating
Other
Medical Antithrombotic Coatings Segment by Application
Medical Devices
Hemodialysis Tubing
Vascular Stents
Other
Medical Antithrombotic Coatings Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Antithrombotic Coatings market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Antithrombotic Coatings and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Antithrombotic Coatings.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Antithrombotic Coatings market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Antithrombotic Coatings industry.
Chapter 3: Detailed analysis of Medical Antithrombotic Coatings market competition landscape. Including Medical Antithrombotic Coatings manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Medical Antithrombotic Coatings by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Medical Antithrombotic Coatings in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Phosphorylcholine
- PEG Coating
- Heparin Coating
- Other
Applications
- Medical Devices
- Hemodialysis Tubing
- Vascular Stents
- Other
Companies covered
- Thermal Spray Technologies
- Surmodics
- Surface Solutions Group
- Specialty Coating Systems (SCS)
- Hydromer
- Harland Medical Systems
- Coatings2Go
- Biocoat
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Antithrombotic Coatings Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Antithrombotic Coatings Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Medical Antithrombotic Coatings Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Medical Antithrombotic Coatings Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Medical Antithrombotic Coatings Market Dynamics
- 2.1 Medical Antithrombotic Coatings Industry Trends
- 2.2 Medical Antithrombotic Coatings Industry Drivers
- 2.3 Medical Antithrombotic Coatings Industry Opportunities and Challenges
- 2.4 Medical Antithrombotic Coatings Industry Restraints
3 Medical Antithrombotic Coatings Market by Manufacturers
- 3.1 Global Medical Antithrombotic Coatings Production Value by Manufacturers (2021-2026)
- 3.2 Global Medical Antithrombotic Coatings Production by Manufacturers (2021-2026)
- 3.3 Global Medical Antithrombotic Coatings Average Price by Manufacturers (2021-2026)
- 3.4 Global Medical Antithrombotic Coatings Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Antithrombotic Coatings Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Antithrombotic Coatings Manufacturers, Product Type & Application
- 3.7 Global Medical Antithrombotic Coatings Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Antithrombotic Coatings Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Antithrombotic Coatings Players Market Share by Production Value in 2025
- 3.8.3 2025 Medical Antithrombotic Coatings Tier 1, Tier 2, and Tier 3
4 Medical Antithrombotic Coatings Market by Type
- 4.1 Medical Antithrombotic Coatings Type Introduction
- 4.1.1 Phosphorylcholine
- 4.1.2 PEG Coating
- 4.1.3 Heparin Coating
- 4.1.4 Other
- 4.2 Global Medical Antithrombotic Coatings Production by Type
- 4.2.1 Global Medical Antithrombotic Coatings Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Antithrombotic Coatings Production by Type (2021-2032)
- 4.2.3 Global Medical Antithrombotic Coatings Production Market Share by Type (2021-2032)
- 4.3 Global Medical Antithrombotic Coatings Production Value by Type
- 4.3.1 Global Medical Antithrombotic Coatings Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Antithrombotic Coatings Production Value by Type (2021-2032)
- 4.3.3 Global Medical Antithrombotic Coatings Production Value Market Share by Type (2021-2032)
5 Medical Antithrombotic Coatings Market by Application
- 5.1 Medical Antithrombotic Coatings Application Introduction
- 5.1.1 Medical Devices
- 5.1.2 Hemodialysis Tubing
- 5.1.3 Vascular Stents
- 5.1.4 Other
- 5.2 Global Medical Antithrombotic Coatings Production by Application
- 5.2.1 Global Medical Antithrombotic Coatings Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Antithrombotic Coatings Production by Application (2021-2032)
- 5.2.3 Global Medical Antithrombotic Coatings Production Market Share by Application (2021-2032)
- 5.3 Global Medical Antithrombotic Coatings Production Value by Application
- 5.3.1 Global Medical Antithrombotic Coatings Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Antithrombotic Coatings Production Value by Application (2021-2032)
- 5.3.3 Global Medical Antithrombotic Coatings Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermal Spray Technologies
- 6.1.1 Thermal Spray Technologies Company Information
- 6.1.2 Thermal Spray Technologies Business Overview
- 6.1.3 Thermal Spray Technologies Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.1.4 Thermal Spray Technologies Medical Antithrombotic Coatings Product Portfolio
- 6.1.5 Thermal Spray Technologies Recent Developments
- 6.2 Surmodics
- 6.2.1 Surmodics Company Information
- 6.2.2 Surmodics Business Overview
- 6.2.3 Surmodics Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.2.4 Surmodics Medical Antithrombotic Coatings Product Portfolio
- 6.2.5 Surmodics Recent Developments
- 6.3 Surface Solutions Group
- 6.3.1 Surface Solutions Group Company Information
- 6.3.2 Surface Solutions Group Business Overview
- 6.3.3 Surface Solutions Group Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.3.4 Surface Solutions Group Medical Antithrombotic Coatings Product Portfolio
- 6.3.5 Surface Solutions Group Recent Developments
- 6.4 Specialty Coating Systems (SCS)
- 6.4.1 Specialty Coating Systems (SCS) Company Information
- 6.4.2 Specialty Coating Systems (SCS) Business Overview
- 6.4.3 Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.4.4 Specialty Coating Systems (SCS) Medical Antithrombotic Coatings Product Portfolio
- 6.4.5 Specialty Coating Systems (SCS) Recent Developments
- 6.5 Hydromer
- 6.5.1 Hydromer Company Information
- 6.5.2 Hydromer Business Overview
- 6.5.3 Hydromer Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.5.4 Hydromer Medical Antithrombotic Coatings Product Portfolio
- 6.5.5 Hydromer Recent Developments
- 6.6 Harland Medical Systems
- 6.6.1 Harland Medical Systems Company Information
- 6.6.2 Harland Medical Systems Business Overview
- 6.6.3 Harland Medical Systems Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.6.4 Harland Medical Systems Medical Antithrombotic Coatings Product Portfolio
- 6.6.5 Harland Medical Systems Recent Developments
- 6.7 Coatings2Go
- 6.7.1 Coatings2Go Company Information
- 6.7.2 Coatings2Go Business Overview
- 6.7.3 Coatings2Go Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.7.4 Coatings2Go Medical Antithrombotic Coatings Product Portfolio
- 6.7.5 Coatings2Go Recent Developments
- 6.8 Biocoat
- 6.8.1 Biocoat Company Information
- 6.8.2 Biocoat Business Overview
- 6.8.3 Biocoat Medical Antithrombotic Coatings Production, Value and Gross Margin (2021-2026)
- 6.8.4 Biocoat Medical Antithrombotic Coatings Product Portfolio
- 6.8.5 Biocoat Recent Developments
7 Global Medical Antithrombotic Coatings Production by Region
- 7.1 Global Medical Antithrombotic Coatings Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Medical Antithrombotic Coatings Production by Region (2021-2032)
- 7.2.1 Global Medical Antithrombotic Coatings Production by Region (2021-2026)
- 7.2.2 Global Medical Antithrombotic Coatings Production Forecast by Region (2027-2032)
- 7.3 Global Medical Antithrombotic Coatings Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Medical Antithrombotic Coatings Production Value by Region (2021-2032)
- 7.4.1 Global Medical Antithrombotic Coatings Production Value by Region (2021-2026)
- 7.4.2 Global Medical Antithrombotic Coatings Production Value by Region (2027-2032)
- 7.5 Global Medical Antithrombotic Coatings Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Medical Antithrombotic Coatings Production Value (2021-2032)
- 7.6.2 Europe Medical Antithrombotic Coatings Production Value (2021-2032)
- 7.6.3 Asia-Pacific Medical Antithrombotic Coatings Production Value (2021-2032)
- 7.6.4 South America Medical Antithrombotic Coatings Production Value (2021-2032)
- 7.6.5 Middle East & Africa Medical Antithrombotic Coatings Production Value (2021-2032)
8 Global Medical Antithrombotic Coatings Consumption by Region
- 8.1 Global Medical Antithrombotic Coatings Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Medical Antithrombotic Coatings Consumption by Region (2021-2032)
- 8.2.1 Global Medical Antithrombotic Coatings Consumption by Region (2021-2026)
- 8.2.2 Global Medical Antithrombotic Coatings Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Medical Antithrombotic Coatings Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Medical Antithrombotic Coatings Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Medical Antithrombotic Coatings Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Medical Antithrombotic Coatings Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Medical Antithrombotic Coatings Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Medical Antithrombotic Coatings Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Medical Antithrombotic Coatings Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Medical Antithrombotic Coatings Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Medical Antithrombotic Coatings Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Medical Antithrombotic Coatings Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Antithrombotic Coatings Value Chain Analysis
- 9.1.1 Medical Antithrombotic Coatings Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Antithrombotic Coatings Production Mode & Process
- 9.2 Medical Antithrombotic Coatings Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Antithrombotic Coatings Distributors
- 9.2.3 Medical Antithrombotic Coatings Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst